GOV — GOVERNMENT

NHLBI Catalyze Program (translational product development)

NHLBI, NIH

Award

R61/R33 grants + in-kind IND-enabling services

Deadline

Services EOI window Sept 14 – Oct 2, 2026

Award type

Cash grant

Focus

Preclinical & therapeutics

Preclinical product development for heart, lung, and blood conditions. Two arms: grant NOFOs such as RFA-HL-26-017 (Product Definition R61/R33, covering target identification and validation through lead series), and Catalyze Preclinical Services, which delivers CRO/CMO IND-enabling work in kind.

Why it's in this index

The heart and blood remit covers a BTHS cardiomyopathy or neutropenia therapeutic — two of the disease's defining features map onto this institute's scope.

Who can apply

Academic and small-business investigators; the services arm requires an Expression of Interest and milestone agreements.

How to apply

Grants via eRA Commons / Grants.gov (see the RFA); services via an EOI at nhlbicatalyze.org — the next window is Sept 14 – Oct 2, 2026.

Links & downloads

NHLBI Catalyze ↗Catalyze services (EOI) ↗RFA-HL-26-017 ↗